EuroIntervention PCRonline - Connecting with the community

Gregg W. Stone

52 articles

Very late scaffold thrombosis: is prolonged DAPT the answer?

EuroIntervention 2017;13:e139-e141 published online e-edition June 2017

Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus eluting bioresorbable polylactide scaffold in comparison with the cobalt chromium metallic stent?

EuroIntervention 2017; just accepted article published in March 2017

Impact of lesion calcification on angiographic outcomes after Absorb everolimus-eluting bioresorbable vascular scaffold implantation: an observation from the ABSORB Japan trial

EuroIntervention 2017;12:1738-1746 published online November 2016

Published in Volume 12 Number 14, February 2017

Impact of time to treatment on the effects of bivalirudin vs. glycoprotein IIb/IIIa inhibitors and heparin in patients undergoing primary percutaneous coronary intervention: insights from the HORIZONS-AMI trial

EuroIntervention 2016;12:1144-1153

Published in Volume 12 Number 9, October 2016

Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial

EuroIntervention 2016;12:1090-1101 published online ahead of print September 2016

Published in Volume 12 Number 9, October 2016

Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold?

EuroIntervention 2016;12:e998-e1008 published online e-edition October 2016

Published in Volume 12 Number 8, October 2016

Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial

EuroIntervention 2016;12:861-872

Published in Volume 12 Number 7, September 2016

In vivo delivery and long-term tissue retention of nano-encapsulated sirolimus using a novel porous balloon angioplasty system

EuroIntervention 2016;12:740-747 published online ahead of print October 2015

Published in Volume 12 Number 6, August 2016

Statin use prior to angiography for the prevention of contrast-induced acute kidney injury: a meta-analysis of 19 randomised trials

EuroIntervention 2016;12:366-374 published online ahead of print May 2015

Published in Volume 12 Number 3, June 2016

Significance of prior percutaneous revascularisation in patients with acute coronary syndromes: insights from the prospective PROSPECT registry

EuroIntervention 2016;11:1468-1474

Published in Volume 11 Number 13, April 2016

Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index

EuroIntervention 2015;11:634-642 published online ahead of print October 2014

Published in Volume 11 Number 6, October 2015

Incidence, predictors, and impact of neurological events in non-ST-segment elevation acute coronary syndromes: the ACUITY trial

EuroIntervention 2015;11:399-406 published online ahead of print July 2014

Published in Volume 11 Number 4, August 2015

Prognostic impact of multivessel versus culprit vessel only percutaneous intervention for patients with multivessel coronary artery disease presenting with acute coronary syndrome

EuroIntervention 2015;11:293-300 published online ahead of print August 2014

Published in Volume 11 Number 3, July 2015

Pressure-controlled intermittent coronary sinus occlusion (PICSO) in acute ST-segment elevation myocardial infarction: results of the Prepare RAMSES safety and feasibility study

EuroIntervention 2015;11:37-44 published online ahead of print March 2015

Published in Volume 11 Number 1, May 2015

The EXCEL and NOBLE trials: similarities, contrasts and future perspectives for left main revascularisation

EuroIntervention 2015;11:V115-V119

Published in Volume 11 Supplement V, May 2015

Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials

EuroIntervention 2014;10:97-104 published online ahead of print September 2013

Published in Volume 10 Number 1, May 2014

Mechanical complications of everolimus-eluting stents associated with adverse events: an intravascular ultrasound study

EuroIntervention 2014;9:1301-1308

Published in Volume 9 Number 11, March 2014

Bioresorbable vascular scaffolds: is imaging everything?

EuroIntervention 2014;9:1255-1257

Published in Volume 9 Number 11, March 2014

Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMI

EuroIntervention 2014;9:1195-1201 published online ahead of print June 2013

Published in Volume 9 Number 10, February 2014

Impact of bifurcation target lesion on angiographic, electrocardiographic, and clinical outcomes of patients undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial)

EuroIntervention 2013;9:817-823

Published in Volume 9 Number 7, November 2013

Effect of pressure-controlled intermittent coronary sinus occlusion (PICSO) on myocardial ischaemia and reperfusion in a closed-chest porcine model

EuroIntervention 20a13;9:398-406

Published in Volume 9 Number 3, July 2013

Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial

EuroIntervention 2013;9:220-227

Published in Volume 9 Number 2, June 2013

Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial

EuroIntervention 2013;8:1307-1314

Published in Volume 8 Number 11, March 2013

Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial

EuroIntervention 2013;8:1134-1142

Published in Volume 8 Number 10, February 2013

An intravascular ultrasound comparison of left anterior descending artery/first diagonal branch versus distal left main coronary artery bifurcation lesions

EuroIntervention 2013;8:1040-1046

Published in Volume 8 Number 9, January 2013

Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial

EuroIntervention 2013;8:1033-1039

Published in Volume 8 Number 9, January 2013

Age- and gender-related changes in plaque composition in patients with acute coronary syndrome: the PROSPECT study

EuroIntervention 2012;8:929-938

Published in Volume 8 Number 8, December 2012

Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trial

EuroIntervention 2012;8:724-731

Published in Volume 8 Number 6, October 2012

Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials

EuroIntervention 2012;8:599-606

Published in Volume 8 Number 5, September 2012

Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trials

EuroIntervention 2012;8:187-195 publish online ahead of print March 2012

Published in Volume 8 Number 2, June 2012

Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials

EuroIntervention 2012;8:87-93

Published in Volume 8 Number 1, May 2012

Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents

EuroIntervention 2012;7:1030-1042

Published in Volume 7 Number 9, January 2012

Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial

EuroIntervention 2011;7:905-916

Published in Volume 7 Number 8, December 2011

First clinical evaluation of a luminal self-expanding shield in patients with intermediate coronary lesions

EuroIntervention 2011;7:780-788

Published in Volume 7 Number 7, November 2011

Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial

EuroIntervention 2011;7:307-313

Published in Volume 7 Number 3, July 2011

The platinum small vessel trial: evaluation of the novel thin-strut platinum-chromium promus element small vessel everolimus-eluting stent

Published in Volume 7 Supplement M, May 2011

Clinical utility of biomarkers to predict major bleeding events after STEMI: a Horizons-AMI substudy with 3-year follow-up

Published in Volume 7 Supplement M, May 2011

PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses

EuroIntervention 2011;7:84-90

Published in Volume 7 Number 1, May 2011

Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trials

EuroIntervention 2011;7:74-83

Published in Volume 7 Number 1, May 2011

Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial

EuroIntervention Supplement (2010) Vol. 6 (Supplement J) J44-J52

Published in Volume 6 Supplement J, December 2010

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial

EuroIntervention 2010;6:437-446 - DOI10.4244/EIJV6I4A75

Published in Volume 6 Number 4, September 2010

Predictors of clinical outcomes in the SPIRIT IV randomised trial of everolimus-eluting and paclitaxel-eluting stents

Published in Volume 6 Supplement H, May 2010

Percutaneous treatment of functional mitral repair: 3-year results from the Evolution I study

Published in Volume 6 Supplement H, May 2010

Predictors of stent thrombosis in the SPIRIT IV randomised trial of everolimus-eluting and paclitaxel-eluting stents - is there a difference between drug-eluting stents?

Published in Volume 6 Supplement H, May 2010

A pooled gender based analysis comparing the XIENCE V® everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis

EuroIntervention 2010;5:788-794

Published in Volume 5 Number 7, February 2010

Correlations between epicardial flow, microvascular reperfusion, infarct size and clinical outcomes in patients with anterior versus non-anterior myocardial infarction treated with primary or rescue angioplasty: analysis from the EMERALD trial

EuroIntervention 2009;5:417-424 - DOI10.4244/EIJV5I4A66

Published in Volume 5 Number 4, September 2009

Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting

EuroIntervention 2009;5:177-189

Published in Volume 5 Number 2, June 2009

Gender differences in stent thrombosis: insights from TAXUS WOMAN

Published in Volume 5 Supplement E, May 2009

Percutaneous treatment of functional mitral repair. 2-years results from the EVOLUTION I study.

Published in Volume 5 Supplement E, May 2009

Intracoronary navigation and positioning using the MediGuide gMPS enabled GMC system

Published in Volume 5 Supplement E, May 2009

Choice of arterial access site and outcomes in patients with acute coronary syndromes managed with an early invasive strategy: the ACUITY trial

EuroIntervention 2009;5:115-120

Published in Volume 5 Number 1, May 2009

Integrated analysis of medically treated diabetic patients in the TAXUS® program: benefits across stent platforms, paclitaxel release formulations, and diabetic treatments

EuroIntervention 2006;2:61-68 - DOI10.4244/EIJV2I1A11

Published in Volume 2 Number 1, May 2006